gvtcx

NHS Framework Agreement for Aflibercept injection and Ranibizumab injection

NHS England Published 3 Jul 2018 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Value£1,220,000,000
Statusactive
Category (CPV) 33600000
RegionNorth East, North West, Yorkshire and the Humber, East Midlands, West Midlands, East of England, London, South East, South West
Deadline10 Aug 2018
Contract start1 Oct 2018
Contract end30 Sept 2020
Procedureopen
SME suitableYes
OCIDocds-b5fd17-2185a72e-57ad-4f00-ad8b-25bf58fff2b3

description

NHS Framework Agreement for Proprietary Pharmaceuticals - Afliercept and Ranibizumab ophthalmology products

Offer reference number: CM/PHR/17/5561

Period of framework agreement: 1 August 2018 - 31 July 2020 (at the Authority's discretion) for a period or periods up to a total of 24 months

documents

Documents are linked, not mirrored. They are served by the publishing authority and may require registration.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
3 Jul 2018 Tender (tender) · d18aaa94-0e16-4f83-a972-a4171450a216-225936

more from NHS England

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.